In addition, leukemia inhibitory factor could maintain the stemness of glioma stem cells, and EGF, bFGF, and leukemia inhibitory factor together enable the expansion of neural stem cells in culture and allow them to retain their multipotency for at least 1 year in vitro [50]. The gene discussed is LIF; the disease is glioma.